Effects of diene valepotriates from valeriana glechomifolia on Na+/K+-ATPase activity in the cortex and hippocampus of mice

Planta Medica

Volumn 81, Issue 3, 2015, Pages 200-207

  Müller, Liz G ^a   Salles, Luisa ^a   Lins, Helena A ^b   Feijó, Priscilla R O ^b   Cassel, Eduardo ^c   Vargas, Rubem ^c   Von Poser, Gilsane L ^a   Noël, François ^b   Quintas, Luis E M ^b   Rates, Stela M K ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

antidepressant; forced swimming test; Na+ K+ ATPase activity; valepotriates; Valeriana glechomifolia; Valerianaceae

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ANTIDEPRESSANT AGENT; DIENE VALEPOTRIATE; PLANT MEDICINAL PRODUCT; SODIUM POTASSIUM ADENOSINE TRIPHOSPHATASE ALPHA1; SODIUM POTASSIUM ADENOSINE TRIPHOSPHATASE ALPHA2; SODIUM POTASSIUM ADENOSINE TRIPHOSPHATASE ALPHA3; UNCLASSIFIED DRUG; IRIDOID; ISOPROTEIN; PLANT EXTRACT; VALERIAN; VALTRATES (COMBINATION);

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDEPRESSANT ACTIVITY; ARTICLE; BRAIN CORTEX; BRAIN REGION; CONTROLLED STUDY; DEPRESSION; DRUG STRUCTURE; ENZYME ACTIVITY; FORCED SWIM TEST; HIPPOCAMPUS; IMMOBILITY; IN VIVO STUDY; LOCOMOTION; MALE; MOUSE; NEUROBIOLOGY; NONHUMAN; OPEN FIELD TEST; PROTEIN CONTENT; PROTEIN EXPRESSION; TREATMENT DURATION; VALERIANA; VALERIANA GLECHOMIFOLIA; ANIMAL; BRAIN; CHEMISTRY; DRUG EFFECTS; DRUG THERAPY; MENTAL STRESS; METABOLISM; MOTOR ACTIVITY; PHYTOTHERAPY; SWIMMING;

ANIMALIA; MUS; RATTUS; VALERIANA GLECHOMIFOLIA; VALERIANACEAE;

ANIMALS; ANTIDEPRESSIVE AGENTS; BRAIN; CEREBRAL CORTEX; HIPPOCAMPUS; IRIDOIDS; MALE; MICE; MOTOR ACTIVITY; PHYTOTHERAPY; PLANT EXTRACTS; PROTEIN ISOFORMS; SODIUM-POTASSIUM-EXCHANGING ATPASE; STRESS, PSYCHOLOGICAL; SWIMMING; VALERIAN;

EID: 84923380581     PISSN: 00320943     EISSN: 14390221     Source Type: Journal    
DOI: 10.1055/s-0034-1396200     Document Type: Article

References (69)

1. Backlund A., Moritz T. Phylogenetic implications of an expanded valepotriate distribution in the Valerianaceae. Biochem System Ecol: 1998; 26 309 335
2. Hatesohl M., Feistel B., Sievers H., Lehnfeld R., Hegger M., Winterhoff H. Extracts of Valeriana officinalis L. show anxiolitic and antidepressant effects but neither sedative nor myorelaxant properties. Phytomedicine: 2008; 15 2 15
3. Murphy K., Kubin Z. J., Shepherd J. N., Ettinger R. H. Valeriana officinalis root extracts have potent anxiolytic effects in laboratory rats. Phytomedicine: 2010; 17 674 678
4. Subhan F., Karim N., Gilani A. H., Sewell R. DE. Terpenoid content of Valeriana wallichii extracts and antidepressant-like response profiles. Phytother Res: 2010; 24 686 691
5. Sah S. P., Mathela C. S., Chopra K. Antidepressant effect of Valeriana wallichii patchouli alcohol chemotype in mice: behavioural and biochemical evidence. J Ethnopharmacol: 2011; 135 197 200
6. World Health Organization WHO Monographs on selected medicinal Plants. Malta WHO Graphics: 1999
7. Holzmann I., Filho V. C., Mora T. C., Cáceres A., Martínez J. V., Cruz S. M., Souza M. M. Evaluation of behavioral and pharmacological effects of hydroalcoholic extract of Valeriana prionophylla Standl. from Guatemala. Evid Based Complement Alternat Med: 2011; 2011 1 9
8. Liu X. G., Gao P. Y., Wang G. S., Song S. J., Li L. Z., Li X., Yao X. S., Zhang Z. X. In vivo antidepressant activity of sesquiterpenes from the roots of Valeriana fauriei Briq. Fitoterapia: 2012; 83 599 603
9. A receptors as in vivo substrate for the anxiolytic action of valerenic acid, a major constituent of valerian root extracts. Neuropharmacology: 2009; 56 174 181
10. Marder M., Viola H., Wasowski C., Fernández S., Medina J. H., Paladini A. C. 6-Methylapigenin and hesperidin: new Valeriana flavonoids with activity on the CNS. Pharmacol Biochem Behav: 2003; 75 537 545
11. Andreatini R., Leite J. R. Effect of valepotriates on the behavior of rats in the elevated plus-maze during diazepam withdrawal. Eur J Pharmacol: 1994; 1 233 235
12. Andreatini R., Sartori V. A., Seabra M. L., Leite J. R. Effect of valepotriates (valerian extract) in generalized anxiety disorder: a randomized placebo-controlled pilot study. Phytoter Res: 2002; 165 650 654
13. Maurmann N., Reolon G. K., Rech S. B., Fett-Neto A. G., Roesler R. A valepotriate fraction of Valeriana glechomifolia shows sedative and anxiolytic properties and impairs recognition but not aversive memory in mice. Evid Based Complement Alternat Med: 2011; 2011 1 7
14. Salles L. A., Silva A. L., Rech S. B., Zanatta N., Von Poser G. L. Constituents of Valeriana glechomifolia Meyer. Biochem Syst Ecol: 2000; 28 907 910
15. Silva A. L., Rech S. B., von Poser G. L. Quantitative determination of valepotriates from Valeriana native to south Brazil. Planta Med: 2002; 68 570 572
16. Müller L. G., Salles L. A., Stein A. C., Betti A. H., Sakamoto S., Cassel E., Vargas R. F., von Poser G. L., Rates S. MK. Antidepressant-like effect of Valeriana glechomifolia Meyer (Valerianaceae) in mice. Prog Neuropsychopharmacol Biol Psychiatry: 2012; 36 101 109
17. Bettero G. M., Salles L., Rosário R. MF, von Poser G. L., Rates S. MK, Noël F., Quintas L. EM. In vitro effect of valepotriates isolated from Valeriana glechomifolia on rat P-type ATPases. Planta Med: 2011; 77 1702 1706
18. +-ATPase. Annu Rev Biochem: 2002; 71 511 535
19. +-ATPase. Front Biosci: 2005; 10 2373 2396
20. +-ATPase and endogenous digitalis-like compounds in depressive disorders. Biol Psychiatry: 2006; 60 491 499
21. Goldstein I., Lerer E., Laiba E., Mallet J., Mujaheed M., Laurent C., Rosen H., Ebstein R. P., Lichtstein D. Association between sodium-and potassium-activated adenosine triphosphatase α isoforms and bipolar disorders. Biol Psychiatry: 2009; 65 985 991
22. +-ATPase activity in rats subjected to an experimental model of depression. Neurochem Res: 2003; 28 1339 1344
23. +-ATPase activity is reduced in hippocampus of rats submitted to an experimental model of depression: effect of chronic lithium treatment and possible involvement in learning deficits. Neurobiol Learn Mem: 2005; 84 102 110
24. +-ATPase activity isreduced in amygdala of rats with chronic stress-induced anxiety-like behavior. Neurochem Res: 2010; 35 1787 1795
25. + ATPase. J Neurosci: 1991; 11 381 391
26. + ATPase α 2 isoform is expressed in neurons, and its absence disrupts neuronal activity in newborn mice. J Biol Chem: 2003; 278 5317 5324
27. Gritz S. M., Radcliffe R. A. Genetic effects of ATP1A2 in familial hemiplegic migraine type II and animal models. Hum Genomics: 2013; 7 8 14
28. Heinzen E. L., Arzimanoglou A., Brashear A., Clapcote S. J., Gurrieri F., Goldstein D. B., Jóhannesson S. H., Mikati M. A., Neville B., Nicole S., Ozelius L. J., Poulsen H., Schyns T., Sweadner K. J., van den Maagdenberg A., Vilsen B. Distinct neurological disorders with ATP1A3 mutations. Lancet Neurol: 2014; 13 503 514
29. De Fusco M., Marconi R., Silvestri L., Atorino L., Rampoldi L., Morgante L., Ballabio A., Aridon P., Casari G. Haploinsufficiency of ATP1A2 encoding the Na/K pump 2 subunit associated with familial hemiplegic migraine type 2. Nat Genet: 2003; 33 192 196
30. +-ATPase α 3 gene ATP1A3 are associated with rapid-onset dystonia parkinsonism. Neuron: 2004; 43 169 175
31. Heinzen E. L., Swoboda K. J., Hitomi Y., Gurrieri F., Nicole S., de Vries B., Tiziano F. D., Fontaine B., Walley N. M., Heavin S., Panagiotakaki E., Fiori S., Abiusi E., Di Pietro L., Sweney M. T., Newcomb T. M., Viollet L., Huff C., Jorde L. B., Reyna S. P., Murphy K. J., Shianna K. V., Gumbs C. E., Little L., Silver K., Ptáček L. J., Haan J., Ferrari M. D., Bye A. M., Herkes G. K., Whitelaw C. M., Webb D., Lynch B. J., Uldall P., King M. D., Scheffer I. E., Neri G., Arzimanoglou A., van den Maagdenberg A. M., Sisodiya S. M., Mikati M. A., Goldstein D. B. De novo mutations in ATP1A3 cause alternating hemiplegia of childhood. Nat Genet: 2012; 44 1030 1034
32. Demos M. K., van Karnebeek C. D., Ross C. J., Adam S., Shen Y., Zhan S. H., Shyr C., Horvath G., Suri M., Fryer A., Jones S. J., Friedman J. M. A novel recurrent mutation in ATP1A3 causes CAPOS syndrome. Orphanet J Rar Dis: 2014; 9 15 23
33. +-ATPase activity in ATP1A3 heterozygous mice increases susceptibility to depression-like endophenotypes by chronic variable stress. Genes Brain Behav: 2011; 10 542 550
34. Tochigi M., Iwamoto K., Bundo M., Sasaki T., Kato N., Kato T. Gene expression profiling of major depression and suicide in the prefrontal cortex of postmortem brains. Neurosci Res: 2008; 60 184 191
35. Berton O., Nestler E. J. New approaches to antidepressant drug discovery: beyond monoamines. Nat Rev Neurosci: 2006; 7 137 141
36. Price J. L., Drevets W. C. Neurocircuitry of mood disorders. Neuropsychopharmacology: 2010; 35 192 216
37. Viana A. F., Rates S. MK, Naudin B., Janin F., Costentin J., do Rego J. C. Effects of acute or 3-day treatments of Hypericum caprifoliatum Cham. & Schltdt. (Guttifereae) extract of two established antidepressants on basal and stress induced increase in serum and brain corticosterone levels. J Psychopharmacol: 2008; 22 681 690
38. Stein A. C., Viana A. F., Müller L. G., Nunes J. M., Stolz E. D., Do Rego J. C., Costentin J., von Poser G. L., Rates S. M. Uliginosin B, a phloroglucinol derivative from Hypericum polyanthemum: a promising new molecular pattern for the development of antidepressant drugs. Behav Brain Res: 2012; 228 66 73
39. Erhardt E., Zibetti L. C., Godinho J. M., Bacchieri B., Barros H. M. Behavioral changes induced by cocaine in mice are modified by a hyperlipidic diet or recombinant leptin. Braz J Med Biol Res: 2006; 39 1625 1635
40. Petit-Demouliere B., Chenu F., Bourin M. Forced swimming test in mice: a review of antidepressant activity. Psychopharmacology: 2005; 177 245 255
41. Porsolt R. D., Anton G., Blavet N., Jafre M. Behavioral despair in rats: a new model sensitive to antidepressant treatments. Eur J Pharmacol: 1978; 47 379 391
42. Zanatta L. M., Nascimento F. C., Barros S. V., Silva G. R., Zugno A. I., Netto C. A., Wyse A. TS. In vivo and in vitro effect of imipramine and fluoxetine on Na,K-ATPase activity in synaptic plasma membranes from the cerebral cortex of rats. Braz J Med Biol Res: 2001; 34 1265 1269
43. +-ATPase activity in different regions of adult rat brain. Drug Chem Toxicol: 2003; 26 117 124
44. + ATPase hypothesis for bipolar illness. Biol Psychiatry: 1995; 37 235 244
45. Willner P. Chronic mild stress (CMS) revisited: consistency and behavioural-neurobiological concordance in the effects of CMS. Neuropsychobiology: 2005; 52 90 110
46. +-ATPase α 2-but not α 1-isoform abundance in heart, muscle, and brain. Am J Physiol: 1991; 260 C958 C964
47. +-ATPase isoform expression in rat heart. Antioxid Redox Signal: 2004; 6 914 923
48. Goto A., Yamada K., Nagoshi H., Terano Y., Omata M. Stress-induced elevation of ouabain-like compound in rat plasma and adrenal. Hypertension: 1995; 26 1173 1176
49. Therien A. G., Blostein R. Mechanisms of sodium pump regulation. Am J Physiol Cell Physiol: 2000; 279 541 566
50. Bersohn M. M. Sodium pump inhibition in sarcolemma from ischemic hearts. J Mol Cell Cardiol: 1995; 27 1483 1489
51. Golden W. C., Brambrink A. M., Traystman R. J., Martin L. J. Failure to sustain recovery of Na,K-ATPase function is a possible mechanism for striatal neurodegeneration in hypoxic-ischemic newborn piglets. Brain Res Mol Brain Res: 2001; 88 94 102
52. Jamme I., Trouvé P., Maixent J. M., Gerbi A., Charlemagne D., Nouvelot A. Regulation of Na+,K(+)-ATPase alpha subunit isoforms in mouse cortex during focal ischemia. Ann N Y Acad Sci: 1997; 834 658 660
53. +-ATPase during focal cerebral ischaemia in the mouse. Brain Res: 1997; 774 123 130
54. Sun H., Zhang L., Ren C., Chen C., Fan S., Xia J. J., Lin H., Hu C. The expression of Na, K-ATPase in Litopenaeus vannamei under salinity stress. Mar Biol Res: 2011; 7 623 628
55. Wang L., Wang W. N., Liu Y., Cai D. X., Li J. Z., Wang A. L. Two types of ATPases from the Pacific white shrimp, Litopenaeus vannamei in response to environmental stress. Mol Biol Rep: 2012; 39 6427 6438
56. + adenosine triphosphatase α subunit gene (ATP1A3). Biol Psychiatry: 1998; 44 47 51
57. +-adenosine triphosphatase is reduced in temporal cortex of bipolar individuals. Biol Psychiatry: 1998; 44 892 897
58. +-ATPase α 3-subunit mRNA expression in rat hippocampus. Am J Physiol: 1994; 266 C423 C428
59. +-ATPase: mechanisms underlying rapid and sustained changes in pump activity. Am J Physiol: 1995; 269 C295 C311
60. Müller L. G., Salles L. A., Sakamoto S., Stein A. C., Cargnin S. T., Cassel E., Vargas R. F., Rates S. MK, von Poser G. L. Effect of storage time and conditions on the diene valepotriates content of the extract of Valeriana glechomifolia obtained by supercritical carbon dioxide. Phytochem Anal: 2012; 23 222 227
61. Cassel E., Vargas R. MF, Brun G. W., Almeida D. E., Cogoi L., Ferraro G., Filip R. Supercritical fluid extraction of alkaloids from Ilex paraguariensis St. Hill. J Food Eng: 2010; 100 656 661
62. Brazil, Ministério Público Lei n° 11.794, de 8 de outubro de 2008, Brasília-DF, Brazil.
63. Brazil, Ministério da Ciência, Tecnologia e Inovação, CONCEA Diretriz brasileira para o cuidado e a utilização de animais para fins científicos e didáticos-DBCA. Portaria n° 465, de 23 de maio de 2013, Brasília-DF, Brazil.
64. Brazil, Ministério da Ciência, Tecnologia e Inovação, CONCEA Diretrizes da prática de eutanásia do CONCEA. Portaria n. 596, de 25 de junho de 2013, Brasília-DF, Brazil.
65. Porsolt R. D., Bertin A., Jalfre M. Behavioural despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther: 1977; 229 327 336
66. Viana A. F., Do Rego J. C., von Poser G. L., Ferraz A., Heckler A. P., Constantin J., Rates S. MK. The antidepressant-like effect of Hypericum caprifoliatum Cham & Schlecht (Guttiferae) on forced swimming test results from an inhibition of neuronal monoamine uptake. Neuropharmacology: 2005; 49 1042 1052
67. Rezende D. C., Pôças E. S., Muzi-Filho H., Cunha V. M., Caricati-Neto A., Jurkiewicz A., Noël F., Quintas L. EM. Mechanisms associated to impaired activity of cardiac P-type ATPases in endothelial nitric oxide synthase knockout mice. J Physiol Biochem: 2013; 69 207 214
68. Schaffazick N., Amaral L. S., Fonseca T. F., Tomaz M. A., Gaban G. A., Borges P. A., Calil-Elias S., Noël F., Melo P. A., Quintas L. EM, Cunha V. MN. Effect of heparin treatment on the expression and activity of different ion-motive P-type ATPase isoforms from mouse extensor digitorum longus muscle during degeneration and regeneration after Bothrops jararacussu venom injection. Toxicon: 2010; 55 52 60
69. +-ATPase α isoforms expression in stroke-prone spontaneously hypertensive rat heart ventricles: effect of salt loading and lacidipine treatment. Eur J Pharmacol: 2007; 565 151 157